Lumican, a keratin sulfate proteoglycan, is overexpressed in obese patients NASH, thus indicating its potential as a biomarker for NASH in obese patients [79,80]. The gene discussed is LUM; the disease is metabolic dysfunction-associated steatohepatitis.